{"DataElement":{"publicId":"6819951","version":"1","preferredName":"Central Reviewer WHO Classification of Tumors Histologic Grade Histologic Grade","preferredDefinition":"The indicated WHO histologic grade by central review","longName":"CENT_REV_WHO_GRADE","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"6819950","version":"1","preferredName":"Central Reviewer WHO Classification of Tumors Histologic Grade","preferredDefinition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings._The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems._A single person who critically evaluates and reports on laboratory test results, protocols, or other data.","longName":"6819948v1.0:2427327v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"6819948","version":"1","preferredName":"Central Reviewer WHO Classification of Tumors","preferredDefinition":"A single person who critically evaluates and reports on laboratory test results, protocols, or other data.:A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","longName":"C51807:C113304","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Central Reviewer","conceptCode":"C51807","definition":"A single person who critically evaluates and reports on laboratory test results, protocols, or other data.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"WHO Classification of Tumors","conceptCode":"C113304","definition":"A classification of benign and malignant tumors by World Health Organization (WHO) experts based primarily on histologic findings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E0D9952-C94A-32D9-E053-F662850ACCFB","latestVersionIndicator":"Yes","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-07-19","modifiedBy":"ONEDATA","dateModified":"2019-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2427327","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EBA8-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-09","modifiedBy":"ONEDATA","dateModified":"2005-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E0D9952-C958-32D9-E053-F662850ACCFB","latestVersionIndicator":"Yes","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-07-19","modifiedBy":"COBARRUBIAK","dateModified":"2019-07-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6819940","version":"1","preferredName":"World Health Organization Central Nervous System Histologic Grade","preferredDefinition":"A position on a scale of intensity or amount or quality._A United Nations agency established to coordinate international health activities and to help governments improve health services._The part of the nervous system that consists of the brain, spinal cord, and meninges._The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","longName":"6819940v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Not specified","valueDescription":"Not specified","ValueMeaning":{"publicId":"2567693","version":"1","preferredName":"Not specified","longName":"2567693","preferredDefinition":"Not stated explicitly or in detail.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unspecified","conceptCode":"C38046","definition":"Not stated explicitly or in detail.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D57A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"LUY","dateModified":"2015-02-03","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 02/03/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8E0FF20C-50E4-15A6-E053-F662850A1C5E","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-07-19","modifiedBy":"ONEDATA","dateModified":"2019-07-19","deletedIndicator":"No"},{"value":"1","valueDescription":"WHO Central Nervous System Grade I","ValueMeaning":{"publicId":"2581531","version":"1","preferredName":"WHO Central Nervous System Grade I","longName":"2581531","preferredDefinition":"Describes central nervous system tumors that are generally low malignancy, non-infiltrative, and slow growing. Often they can be cured by surgery alone and there is a good chance of long term survival.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 1","conceptCode":"C62394","definition":"Describes central nervous system tumors that are generally low malignancy, non-infiltrative, and slow growing. Often they can be cured by surgery alone and there is a good chance of long term survival.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B88-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FCB876-198E-7B3F-E053-F662850AD421","beginDate":"2019-07-19","endDate":null,"createdBy":"MAESKEB","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"2","valueDescription":"WHO Central Nervous System Grade II","ValueMeaning":{"publicId":"2581532","version":"1","preferredName":"WHO Central Nervous System Grade II","longName":"2581532","preferredDefinition":"A suffix denoting the second person having the same complete name (first, middle, and family names).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 2","conceptCode":"C62395","definition":"Describes central nervous system tumors that are generally relatively slow growing and somewhat infiltrative. They may recur after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B89-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FCB876-19E4-7B3F-E053-F662850AD421","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"3","valueDescription":"WHO Central Nervous System Grade III","ValueMeaning":{"publicId":"2581533","version":"1","preferredName":"WHO Central Nervous System Grade III","longName":"2581533","preferredDefinition":"Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 3","conceptCode":"C62396","definition":"Describes central nervous system tumors that are generally malignant and infiltrative. They tend to recur after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B8A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FCB876-19FA-7B3F-E053-F662850AD421","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"},{"value":"4","valueDescription":"WHO Central Nervous System Grade IV","ValueMeaning":{"publicId":"2581534","version":"1","preferredName":"WHO Central Nervous System Grade IV","longName":"2581534","preferredDefinition":"Describes central nervous system tumors that are generally highly malignant, show rapid and aggressive growth, widely infiltrative, and prone to necrosis. They often recur rapidly after treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"WHO Central Nervous System Grade 4","conceptCode":"C62397","definition":"Describes central nervous system tumors that are generally highly malignant, show rapid and aggressive growth, widely infiltrative, and prone to necrosis. They often recur rapidly after treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0B8B-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-10-31","endDate":null,"createdBy":"UMLLOADER_CAE","dateCreated":"2006-10-31","modifiedBy":"LEEB","dateModified":"2008-10-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"95FCB876-1A10-7B3F-E053-F662850AD421","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7029569","version":"1","preferredName":"World Health Organization Central Nervous System Histologic Grade Grade","preferredDefinition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.:The part of the nervous system that consists of the brain, spinal cord, and meninges.:The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.:A position on a scale of intensity or amount or quality.","longName":"C75419:C12438:C18000:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"World Health Organization","conceptCode":"C75419","definition":"A United Nations agency established to coordinate international health activities and to help governments improve health services.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Central Nervous System","conceptCode":"C12438","definition":"The part of the nervous system that consists of the brain, spinal cord, and meninges.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"95FCB876-199E-7B3F-E053-F662850AD421","latestVersionIndicator":"Yes","beginDate":"2019-10-28","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-10-28","modifiedBy":"ONEDATA","dateModified":"2019-10-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E0FF20C-50CE-15A6-E053-F662850A1C5E","latestVersionIndicator":"Yes","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-07-19","modifiedBy":"COBARRUBIAK","dateModified":"2020-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Central Review WHO Histologic","type":"Preferred Question Text","description":"Central Review WHO Histologic Grade","url":null,"context":"COG"},{"name":"COG CRF Text 10","type":"Alternate Question Text","description":"WHO grade declared by central reviewer:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"8E1038ED-CE7D-01C3-E053-F662850ACE61","latestVersionIndicator":"Yes","beginDate":"2019-07-19","endDate":null,"createdBy":"COBARRUBIAK","dateCreated":"2019-07-19","modifiedBy":"COBARRUBIAK","dateModified":"2020-06-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}